GenomesDAO Raises Undisclosed Amount to Accelerate DTC Efforts and Develop Virtual Labs for Secure Monetization of Genomic Data
GenomesDAO, a biotech company based in London, has secured new funding from investors including Pantera Capital and Modular Capital. The amount of funding raised has not been disclosed. The company plans to use the funds to expand its direct-to-consumer efforts and develop its virtual labs. GenomesDAO offers a secure DNA data storage and sharing application called Genomes.io, which allows individuals to sequence, store, and monetize their genomic data while also providing biotech and pharmaceutical companies with access to genomic data for research and development purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum Classic ($ETC) Eyes a 510% Breakout Rally
Ethereum Classic could surge over 510% to $127.65 as a major breakout pattern emerges.Why the $127.65 Target MattersShould You Pay Attention?
Doginme Made Early Buyers Rich—Now Arctic Pablo Coin Is Leading the Next Meme Coin Gold Rush
While Doginme showed how fast gains can arrive in meme markets, Arctic Pablo Coin is showing how they can be structured, incentivized, and sustainable.Doginme: The Meme Token That Ran With the Big DogsArctic Pablo Coin’s 66% APY: The Meme Coin Presale With Real UtilityIceberg Isle and the Numbers That Matter: $0.000125 Entry, 6,300% ROIArctic Pablo Coin Is Built for the Long Run: Why It Belongs Among the Top New Meme Coins for Exponential Returns
Goldman Sachs Increases Bitcoin ETF Holdings, Surpasses BlackRock
Ethereum’s Rise to $2.5K Sparks Renewed Altcoin Interest
Trending news
MoreCrypto prices
More
